Technology
Latest News
October 28th 2015
October 28, 2015.
Advertisement
Advertisement
October 22, 2015.
October 19, 2015.
October 19, 2015.
Medicine is entering a new era of “gene editing.” Instead of simply being able to “read” our genes, practitioners will be able to adapt and modify DNA sequencing in living cells to treat, cure, and even prevent disease. Defective genes responsible for life-threatening diseases can be rendered harmless by gene editing; it can also be used to develop new, precisely targeted biological drugs based on an individual’s distinct genetic markers. The full list of possibilities, in every area of the life sciences, is simply beyond imagination.
October 16, 2015.
October 09, 2015.
October 08, 2015.
October 08, 2015.
October 07, 2015.
October 07, 2015.
The rising focus on difficulties in swallowing tablets spells a big opportunity for pharma.
October 06, 2015.
October 5, 2015.
October 05, 2015.
October 05, 2015.
October 02, 2015.
October 01, 2015.
Life sciences companies must go beyond digitizing individual operations, and instead harness digital to design and construct entirely new business models, writes Brags Srinivasan.
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
3
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
4
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
5
